US 10927346
Enhanced immune effector cells and use thereof
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 10927346 (Enhanced immune effector cells and use thereof) held by Fate Therapeutics, Inc. expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Fate Therapeutics, Inc.
- Grant date
- Tue Feb 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K35/545, A61K38/00